MTA Pulpotomy
MTA Pulpotomy is a medical procedure with 9 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
0
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
2 of 2 finished
0.0%
0 ended early
2
trials recruiting
9
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Postoperative Pain After Full Pulpotomy With TheraCal PT, Biodentin, and MTA
Clinical and Radiographic Evaluation of MTA Pulpotomy Versus Conventional Pulpectomy in Primary Molars With Irreversible Pulpitis
Comparing MTA Pulpotomy to Root Canal Treatment in Management of Permanent Molars With Irreversible Pulpitis in Children
3Mixtatin and MTA Vital Pulpotomy in Primary Molars
Post Operative Pain and Oral Health Related Quality of Life Following Pulpotomy VS Extraction of Permanent First Molar
Clinical Trials (9)
Postoperative Pain After Full Pulpotomy With TheraCal PT, Biodentin, and MTA
Clinical and Radiographic Evaluation of MTA Pulpotomy Versus Conventional Pulpectomy in Primary Molars With Irreversible Pulpitis
Comparing MTA Pulpotomy to Root Canal Treatment in Management of Permanent Molars With Irreversible Pulpitis in Children
3Mixtatin and MTA Vital Pulpotomy in Primary Molars
Post Operative Pain and Oral Health Related Quality of Life Following Pulpotomy VS Extraction of Permanent First Molar
Outcome of Full Pulpotomy Using Calcium Silicate Based Materials
Success Rate of Three Capping Materials
Pulpotomy in Mature Permanent Molars Using Biodentine Versus MTA
Is Biodentine, as Successful as, Mineral Trioxide Aggregate
All 9 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 9